Protalix BioTherapeutics (PLX) Free Cash Flow Growth (5y) (2015 - 2026)
Protalix BioTherapeutics (PLX) Free Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - |
| 2 | Nanobiotix | 1,910.87 Bn | 1,910.81 Bn | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.14 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.46 Bn | 37.46 Bn | - |
| 10 | Protalix BioTherapeutics | 192.04 Mn | 181.24 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.48% |
| Dec 31, 2025 | 19.00% |
| Sep 30, 2025 | -4.37% |
| Jun 30, 2025 | 8.42% |
| Mar 31, 2025 | 5.25% |
| Dec 31, 2024 | 25.55% |
| Sep 30, 2024 | 24.00% |
| Jun 30, 2024 | 7.19% |
| Mar 31, 2024 | 20.52% |
| Dec 31, 2023 | 23.95% |
| Sep 30, 2023 | -20.51% |
| Jun 30, 2023 | 21.04% |
| Mar 31, 2023 | 19.22% |
| Dec 31, 2022 | -16.50% |
| Sep 30, 2022 | 2.67% |
| Jun 30, 2022 | 4.04% |
| Mar 31, 2022 | 7.37% |
| Dec 31, 2021 | 11.00% |
| Sep 30, 2021 | 7.61% |
| Jun 30, 2021 | 20.04% |